Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
STRATA Skin Sciences, Inc is a medical devices business based in the US. STRATA Skin Sciences shares (SSKN) are listed on the NASDAQ and all prices are listed in US Dollars. STRATA Skin Sciences employs 115 staff and has a trailing 12-month revenue of around USD$25.3 million.
|Latest market close||USD$1.59|
|52-week range||USD$0.752 - USD$2.44|
|50-day moving average||USD$1.4182|
|200-day moving average||USD$1.3567|
|Wall St. target price||USD$3.92|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.241|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-07)||8.16%|
|1 month (2020-12-15)||0.63%|
|3 months (2020-10-15)||29.27%|
|6 months (2020-07-15)||29.27%|
|1 year (2020-01-15)||-28.38%|
|2 years (2019-01-15)||-45.17%|
|3 years (2018-01-13)||N/A|
|5 years (2016-01-15)||52.88%|
Valuing STRATA Skin Sciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of STRATA Skin Sciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
STRATA Skin Sciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$78,000.
The EBITDA is a measure of a STRATA Skin Sciences's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$25.3 million|
|Gross profit TTM||USD$20.3 million|
|Return on assets TTM||-5%|
|Return on equity TTM||-16.37%|
|Market capitalisation||USD$56.7 million|
TTM: trailing 12 months
There are currently 7,895 STRATA Skin Sciences shares held short by investors – that's known as STRATA Skin Sciences's "short interest". This figure is 5.6% down from 8,359 last month.
There are a few different ways that this level of interest in shorting STRATA Skin Sciences shares can be evaluated.
STRATA Skin Sciences's "short interest ratio" (SIR) is the quantity of STRATA Skin Sciences shares currently shorted divided by the average quantity of STRATA Skin Sciences shares traded daily (recently around 28196.428571429). STRATA Skin Sciences's SIR currently stands at 0.28. In other words for every 100,000 STRATA Skin Sciences shares traded daily on the market, roughly 280 shares are currently held short.
However STRATA Skin Sciences's short interest can also be evaluated against the total number of STRATA Skin Sciences shares, or, against the total number of tradable STRATA Skin Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case STRATA Skin Sciences's short interest could be expressed as 0% of the outstanding shares (for every 100,000 STRATA Skin Sciences shares in existence, roughly 0 shares are currently held short) or 0.0005% of the tradable shares (for every 100,000 tradable STRATA Skin Sciences shares, roughly 1 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against STRATA Skin Sciences.
Find out more about how you can short STRATA Skin Sciences stock.
We're not expecting STRATA Skin Sciences to pay a dividend over the next 12 months.
STRATA Skin Sciences's shares were split on a 1:5 basis on 7 April 2017. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your STRATA Skin Sciences shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for STRATA Skin Sciences shares which in turn could have impacted STRATA Skin Sciences's share price.
Over the last 12 months, STRATA Skin Sciences's shares have ranged in value from as little as $0.752 up to $2.44. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while STRATA Skin Sciences's is 2.4772. This would suggest that STRATA Skin Sciences's shares are significantly more volatile than the average for this exchange and represent a higher risk.
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States and Asia. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC excimer laser and VTRAC lamp systems that are used for the treatment of skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. The company distributes its products internationally through distributors, and domestically directly to physicians. STRATA Skin Sciences, Inc. was founded in 1989 and is based in Horsham, Pennsylvania.
Everything we know about the CDT Environmental Technology Investment Holdings Limited IPO, plus information on how to buy in.
Everything we know about the Viant Technology Inc IPO, plus information on how to buy in.
Steps to owning and managing EVGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ETL, with 24-hour and historical pricing before you buy.
Steps to owning and managing EQBK, with 24-hour and historical pricing before you buy.
Steps to owning and managing EIGI, with 24-hour and historical pricing before you buy.
Steps to owning and managing ELTK, with 24-hour and historical pricing before you buy.
Steps to owning and managing DNKN, with 24-hour and historical pricing before you buy.
Steps to owning and managing DKL, with 24-hour and historical pricing before you buy.
Steps to owning and managing DMAC, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.